Last 12 months
Inside the activity.
0 purchase rows · 83 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 31 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 27 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 8 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2023 Filed Mar 17, 2023 20:36 UTC | GrantEmployee Stock Option (Right to Buy) · Derivative | 78,600 | $0.00 Strike: $9.15 | $0.00 |
DisclosureSEC source: 0001209191-23-019669 · doc4.xml · derivative · entry 1 Tulipano Stephen J · CIK 0001360548 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,600 Underlying: Common Stock · 78,600 shares Expires 2033-03-14 F1 · derivative.exercise_date: The option vests as to 1/48th of the total shares on April 15, 2023 and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date. Read SEC document |
|
| March 15, 2023 Filed Mar 17, 2023 20:33 UTC |
Nash Huw M.COO & CBO
|
GrantRestricted Stock Unit (RSU) · Derivative | 52,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-019656 · doc4.xml · derivative · entry 2 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,400 Underlying: Common Stock · 52,400 shares Expires 2027-03-15 F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the issuer through each vesting date. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:33 UTC |
Nash Huw M.COO & CBO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 78,600 | $0.00 Strike: $9.15 | $0.00 |
DisclosureSEC source: 0001209191-23-019656 · doc4.xml · derivative · entry 1 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,600 Underlying: Common Stock · 78,600 shares Expires 2033-03-14 F1 · derivative.exercise_date: The option vests as to 1/48th of the total shares on April 15, 2023 and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:33 UTC |
Kaye Edward M. MDDirector · CEO
|
GrantRestricted Stock Unit (RSU) · Derivative | 142,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-019653 · doc4.xml · derivative · entry 2 Kaye Edward M. MD · CIK 0001522780 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,000 Underlying: Common Stock · 142,000 shares Expires 2027-03-15 F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement. F3 · derivative.exercise_date: The RSUs vest as to 1/4th of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the issuer through each vesting date. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:33 UTC |
Kaye Edward M. MDDirector · CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 213,000 | $0.00 Strike: $9.15 | $0.00 |
DisclosureSEC source: 0001209191-23-019653 · doc4.xml · derivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,000 Underlying: Common Stock · 213,000 shares Expires 2033-03-14 F1 · derivative.exercise_date: The option vests as to 1/48th of the total shares on April 15, 2023 and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date. Read SEC document |
| February 06, 2023 Filed Feb 7, 2023 22:08 UTC |
Ticho BarryChief Medical Officer
|
SaleCommon Stock | 9,235 | $10.02 | $92,491.30 |
DisclosureSEC source: 0001209191-23-007597 · doc4.xml · nonDerivative · entry 2 Ticho Barry · CIK 0001780088 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,725 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.11 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 03, 2023 Filed Feb 7, 2023 22:08 UTC |
Ticho BarryChief Medical Officer
|
SaleCommon Stock | 3,763 | $10.03 | $37,745.15 |
DisclosureSEC source: 0001209191-23-007597 · doc4.xml · nonDerivative · entry 1 Ticho Barry · CIK 0001780088 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,960 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.13 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 02, 2023 Filed Feb 2, 2023 23:32 UTC |
Ticho BarryChief Medical Officer
|
SaleCommon Stock | 267 | $10.00 | $2,670.00 |
DisclosureSEC source: 0001209191-23-006397 · doc4.xml · nonDerivative · entry 3 Ticho Barry · CIK 0001780088 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,723 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 01, 2023 Filed Feb 2, 2023 23:32 UTC |
Ticho BarryChief Medical Officer
|
SaleCommon Stock | 5,705 | $10.02 | $57,140.14 |
DisclosureSEC source: 0001209191-23-006397 · doc4.xml · nonDerivative · entry 2 Ticho Barry · CIK 0001780088 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,990 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.00 to $10.03 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 23:32 UTC |
Ticho BarryChief Medical Officer
|
SaleCommon Stock | 200 | $10.00 | $2,000.00 |
DisclosureSEC source: 0001209191-23-006397 · doc4.xml · nonDerivative · entry 1 Ticho Barry · CIK 0001780088 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,695 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:11 UTC |
Ticho BarryChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 62,000 | $0.00 Strike: $7.07 | $0.00 |
DisclosureSEC source: 0001209191-22-060547 · doc4.xml · derivative · entry 1 Ticho Barry · CIK 0001780088 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,000 Underlying: Common Stock · 62,000 shares Expires 2032-12-06 F1 · derivative.exercise_date: The option vests as to 1/48th of the total shares on January 7, 2023 and then 1/48th of the total shares vest monthly thereafter, subject to reporting person's continued service to the issuer through each vesting date. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:13 UTC | GrantEmployee Stock Option (Right to Buy) · Derivative | 62,000 | $0.00 Strike: $7.07 | $0.00 |
DisclosureSEC source: 0001209191-22-060548 · doc4.xml · derivative · entry 1 Tulipano Stephen J · CIK 0001360548 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,000 Underlying: Common Stock · 62,000 shares Expires 2032-12-06 F1 · derivative.exercise_date: The option vests as to 1/48th of the total shares on January 7, 2023 and then 1/48th of the total shares vest monthly thereafter, subject to reporting person's continued service to the issuer through each vesting date. Read SEC document |
|
| December 07, 2022 Filed Dec 9, 2022 22:10 UTC |
Nash Huw M.COO & CBO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 62,000 | $0.00 Strike: $7.07 | $0.00 |
DisclosureSEC source: 0001209191-22-060546 · doc4.xml · derivative · entry 1 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,000 Underlying: Common Stock · 62,000 shares Expires 2032-12-06 F1 · derivative.exercise_date: The option vests as to 1/48th of the total shares on January 7, 2023 and then 1/48th of the total shares vest monthly thereafter, subject to reporting person's continued service to the issuer through each vesting date. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:08 UTC |
Kaye Edward M. MDDirector · CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 167,050 | $0.00 Strike: $7.07 | $0.00 |
DisclosureSEC source: 0001209191-22-060543 · doc4.xml · derivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,050 Underlying: Common Stock · 167,050 shares Expires 2032-12-06 F1 · derivative.exercise_date: The option vests as to 1/48th of the total shares on January 7, 2023 and then 1/48th of the total shares vest monthly thereafter, subject to reporting person's continued service to the issuer through each vesting date. Read SEC document |
| June 07, 2022 Filed Jun 8, 2022 21:00 UTC |
Krainer Adrian R.Director
|
GrantDirector Stock Option (Right to Buy) · Derivative | 21,000 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0001209191-22-035076 · doc4.xml · derivative · entry 1 Krainer Adrian R. · CIK 0001780081 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2032-06-06 F1 · derivative.exercise_date: The option shall vest on June 7, 2023 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date. Read SEC document |
| June 07, 2022 Filed Jun 8, 2022 21:00 UTC |
LEVIN ARTHUR ADirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 21,000 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0001209191-22-035080 · doc4.xml · derivative · entry 1 LEVIN ARTHUR A · CIK 0001181556 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2032-06-06 F1 · derivative.exercise_date: The option shall vest on June 7, 2023 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date. Read SEC document |
| June 07, 2022 Filed Jun 8, 2022 21:00 UTC |
Menzel Garry EDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 21,000 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0001209191-22-035079 · doc4.xml · derivative · entry 1 Menzel Garry E · CIK 0001556064 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2032-06-06 F1 · derivative.exercise_date: The option shall vest on June 7, 2023 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date. Read SEC document |
| June 07, 2022 Filed Jun 8, 2022 21:00 UTC |
Harrison Seth LoringDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 21,000 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0001209191-22-035077 · doc4.xml · derivative · entry 1 Harrison Seth Loring · CIK 0001404955 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2032-06-06 F1 · derivative.exercise_date: The option shall vest on June 7, 2023 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date. Read SEC document |
| June 07, 2022 Filed Jun 8, 2022 21:00 UTC |
Burstein JenniferDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 21,000 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0001209191-22-035078 · doc4.xml · derivative · entry 1 Burstein Jennifer · CIK 0001640069 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2032-06-06 F1 · derivative.exercise_date: The option shall vest on June 7, 2023 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date. Read SEC document |
| June 07, 2022 Filed Jun 8, 2022 21:00 UTC |
TZIANABOS ARTHURDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 21,000 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0001209191-22-035075 · doc4.xml · derivative · entry 1 TZIANABOS ARTHUR · CIK 0001586226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2032-06-06 F1 · derivative.exercise_date: The option shall vest on June 7, 2023 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date. Read SEC document |
| June 07, 2022 Filed Jun 8, 2022 21:00 UTC |
Smith JulieDirector
|
GrantDirector Stock Option (Right to Buy) · Derivative | 21,000 | $0.00 Strike: $12.96 | $0.00 |
DisclosureSEC source: 0001209191-22-035074 · doc4.xml · derivative · entry 1 Smith Julie · CIK 0001557928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 21,000 shares Expires 2032-06-06 F1 · derivative.exercise_date: The option shall vest on June 7, 2023 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 21:00 UTC | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 11,160 | $0.00 Strike: $4.48 | $0.00 |
DisclosureSEC source: 0001209191-22-034170 · doc4.xml · derivative · entry 2 Tulipano Stephen J · CIK 0001360548 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,837 Underlying: Common Stock · 11,160 shares Expires 2029-03-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested as to 1/4th of the total shares on March 15, 2020, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date. Read SEC document |
|
| June 02, 2022 Filed Jun 3, 2022 21:00 UTC | Exercise / conversionCommon Stock | 11,160 | $4.48 | $49,996.80 |
DisclosureSEC source: 0001209191-22-034170 · doc4.xml · nonDerivative · entry 1 Tulipano Stephen J · CIK 0001360548 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| May 25, 2022 Filed May 26, 2022 21:16 UTC |
Kaye Edward M. MDDirector · CEO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $0.60 | $0.00 |
DisclosureSEC source: 0001209191-22-032259 · doc4.xml · derivative · entry 2 Kaye Edward M. MD · CIK 0001522780 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 622,801 Underlying: Common Stock · 15,000 shares Expires 2028-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested as to 1/4th of the total shares on October 17, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date. Read SEC document |
| May 25, 2022 Filed May 26, 2022 21:16 UTC |
Kaye Edward M. MDDirector · CEO
|
Exercise / conversionCommon Stock | 15,000 | $0.60 | $9,000.00 |
DisclosureSEC source: 0001209191-22-032259 · doc4.xml · nonDerivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 21:15 UTC |
Ticho BarryChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 107,400 | $0.00 Strike: $20.34 | $0.00 |
DisclosureSEC source: 0001209191-22-019686 · doc4.xml · derivative · entry 1 Ticho Barry · CIK 0001780088 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,400 Underlying: Common Stock · 107,400 shares Expires 2032-03-14 F1 · derivative.exercise_date: The option vests as to 1/48th of the total shares on April 15, 2022 and then 1/48th of the total shares vest monthly thereafter, subject to reporting person's continued service to the issuer through each vesting date. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 21:19 UTC |
Kaye Edward M. MDDirector · CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 308,000 | $0.00 Strike: $20.34 | $0.00 |
DisclosureSEC source: 0001209191-22-019689 · doc4.xml · derivative · entry 1 Kaye Edward M. MD · CIK 0001522780 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,000 Underlying: Common Stock · 308,000 shares Expires 2032-03-14 F1 · derivative.exercise_date: The option vests as to 1/48th of the total shares on April 15, 2022 and then 1/48th of the total shares vest monthly thereafter, subject to reporting person's continued service to the issuer through each vesting date. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 21:17 UTC | GrantEmployee Stock Option (Right to Buy) · Derivative | 107,400 | $0.00 Strike: $20.34 | $0.00 |
DisclosureSEC source: 0001209191-22-019687 · doc4.xml · derivative · entry 1 Tulipano Stephen J · CIK 0001360548 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,400 Underlying: Common Stock · 107,400 shares Expires 2032-03-14 F1 · derivative.exercise_date: The option vests as to 1/48th of the total shares on April 15, 2022 and then 1/48th of the total shares vest monthly thereafter, subject to reporting person's continued service to the issuer through each vesting date. Read SEC document |
|
| March 15, 2022 Filed Mar 17, 2022 21:13 UTC |
Nash Huw M.COO & CBO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 107,400 | $0.00 Strike: $20.34 | $0.00 |
DisclosureSEC source: 0001209191-22-019684 · doc4.xml · derivative · entry 1 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,400 Underlying: Common Stock · 107,400 shares Expires 2032-03-14 F1 · derivative.exercise_date: The option vests as to 1/48th of the total shares on April 15, 2022 and then 1/48th of the total shares vest monthly thereafter, subject to reporting person's continued service to the issuer through each vesting date. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:35 UTC |
Nash Huw M.COO & CBO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,800 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001209191-22-001849 · doc4.xml · derivative · entry 5 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,822 Underlying: Common Stock · 3,800 shares Expires 2028-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:35 UTC |
Nash Huw M.COO & CBO
|
SaleCommon Stock | 200 | $24.07 | $4,814.00 |
DisclosureSEC source: 0001209191-22-001849 · doc4.xml · nonDerivative · entry 4 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:35 UTC |
Nash Huw M.COO & CBO
|
SaleCommon Stock | 2,103 | $23.40 | $49,219.03 |
DisclosureSEC source: 0001209191-22-001849 · doc4.xml · nonDerivative · entry 3 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.03 to $23.83 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:35 UTC |
Nash Huw M.COO & CBO
|
SaleCommon Stock | 1,497 | $22.47 | $33,633.10 |
DisclosureSEC source: 0001209191-22-001849 · doc4.xml · nonDerivative · entry 2 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,303 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.98 to $22.95 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:35 UTC |
Nash Huw M.COO & CBO
|
Exercise / conversionCommon Stock | 3,800 | $2.19 | $8,322.00 |
DisclosureSEC source: 0001209191-22-001849 · doc4.xml · nonDerivative · entry 1 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 23:15 UTC |
Nash Huw M.COO & CBO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,700 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001209191-21-067950 · doc4.xml · derivative · entry 4 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,622 Underlying: Common Stock · 5,700 shares Expires 2028-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 23:15 UTC |
Nash Huw M.COO & CBO
|
SaleCommon Stock | 2,500 | $25.06 | $62,656.00 |
DisclosureSEC source: 0001209191-21-067950 · doc4.xml · nonDerivative · entry 3 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.56 to $25.13 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 23:15 UTC |
Nash Huw M.COO & CBO
|
SaleCommon Stock | 3,200 | $23.96 | $76,673.60 |
DisclosureSEC source: 0001209191-21-067950 · doc4.xml · nonDerivative · entry 2 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.45 to $24.42 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 23:15 UTC |
Nash Huw M.COO & CBO
|
Exercise / conversionCommon Stock | 5,700 | $2.19 | $12,483.00 |
DisclosureSEC source: 0001209191-21-067950 · doc4.xml · nonDerivative · entry 1 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 22:05 UTC |
Nash Huw M.COO & CBO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,900 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001209191-21-062772 · doc4.xml · derivative · entry 7 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,322 Underlying: Common Stock · 1,900 shares Expires 2028-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date. Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 22:05 UTC |
Nash Huw M.COO & CBO
|
SaleCommon Stock | 1,900 | $25.00 | $47,500.00 |
DisclosureSEC source: 0001209191-21-062772 · doc4.xml · nonDerivative · entry 5 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 22:05 UTC |
Nash Huw M.COO & CBO
|
Exercise / conversionCommon Stock | 1,900 | $2.19 | $4,161.00 |
DisclosureSEC source: 0001209191-21-062772 · doc4.xml · nonDerivative · entry 4 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 22:05 UTC |
Nash Huw M.COO & CBO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,800 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001209191-21-062772 · doc4.xml · derivative · entry 6 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,222 Underlying: Common Stock · 3,800 shares Expires 2028-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 22:05 UTC |
Nash Huw M.COO & CBO
|
SaleCommon Stock | 1,610 | $23.72 | $38,195.16 |
DisclosureSEC source: 0001209191-21-062772 · doc4.xml · nonDerivative · entry 3 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.68 to $23.76 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 22:05 UTC |
Nash Huw M.COO & CBO
|
SaleCommon Stock | 2,190 | $23.41 | $51,261.33 |
DisclosureSEC source: 0001209191-21-062772 · doc4.xml · nonDerivative · entry 2 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,610 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.67 to $23.66 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 22:05 UTC |
Nash Huw M.COO & CBO
|
Exercise / conversionCommon Stock | 3,800 | $2.19 | $8,322.00 |
DisclosureSEC source: 0001209191-21-062772 · doc4.xml · nonDerivative · entry 1 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 21:51 UTC |
Nash Huw M.COO & CBO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,700 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001209191-21-059111 · doc4.xml · derivative · entry 3 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,022 Underlying: Common Stock · 5,700 shares Expires 2028-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 21:51 UTC |
Nash Huw M.COO & CBO
|
SaleCommon Stock | 5,700 | $24.83 | $141,505.92 |
DisclosureSEC source: 0001209191-21-059111 · doc4.xml · nonDerivative · entry 2 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.42 to $25.38 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 21:51 UTC |
Nash Huw M.COO & CBO
|
Exercise / conversionCommon Stock | 5,700 | $2.19 | $12,483.00 |
DisclosureSEC source: 0001209191-21-059111 · doc4.xml · nonDerivative · entry 1 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 22:30 UTC |
Nash Huw M.COO & CBO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,700 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001209191-21-054552 · doc4.xml · derivative · entry 3 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,722 Underlying: Common Stock · 5,700 shares Expires 2028-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 1/48th of the total shares on November 22, 2018, and then 1/48th of the total shares vest monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 22:30 UTC |
Nash Huw M.COO & CBO
|
SaleCommon Stock | 5,700 | $26.00 | $148,222.80 |
DisclosureSEC source: 0001209191-21-054552 · doc4.xml · nonDerivative · entry 2 Nash Huw M. · CIK 0001780085 · COO & CBO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.68 to $26.49 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.